Tag: Canada

Home / Canada
Post

Health Canada assessing NDMA in ranitidine

Health Canada is informing Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. Health Canada is closely assessing the issue in collaboration with other regulators internationally, including the U.S. Food and Drug Administration and the European Medicines Agency. The Department will take action as needed, and will keep...

Post

Screen for Colon Cancer !

Colorectal Cancer Canada(CCC) states Colorectal Cancer (CRC) deaths are continuing to decline in Canada. This is likely due to improvements in treatment and diagnosis. The decline in CRC death rates are consistent with a relatively large contribution from screening and with a smaller impact of risk factor reductions. CRC develops from precancerous polyps. Screening tests...

Post

Several children’s strawberry-flavoured acetaminophen syrups recalled.

Several children’s strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles.  November 2018 The recall has been expanded to include all lots of children’s strawberry-flavoured acetaminophen syrups labeled as Biomedic, Option+, or Laboratoires Trianon Inc. because of defective child-resistant safety caps. HMC

Post

July 28, 2018 is World Hepatitis Day.

In Canada, 44% of people living with chronic HCV are unaware they have the disease, despite availability of screening and access to effective treatment. In 2017, there were 285 cases of HCV reported to Peel Public Health. Although many cases are initially asymptomatic, early diagnosis and treatment of HCV is important to decrease the risk...

Post

Newer Shingles Vaccine

A new herpes zoster (HZ) subunit vaccine (HZ/su) appears to be more effective especially among elderly and longer duration of protection and less costly than the currently used live attenuated HZ vaccine (ZVL) at all ages, a new study published online January 2 in JAMA Internal Medicine shows. The US Food and Drug Administration (FDA) approved the...

Post

Shortage of EpiPen (0.3 mg) auto-injector in Canada

Pfizer Canada has advised Health Canada that there is currently a shortage of EpiPen auto-injectors in the 0.3 mg format (DIN ‪00509558‬). The shortage is reported to be due to a manufacturing disruption and is currently anticipated to be resolved by ‪March 2, 2018‬. According to Pfizer, the shortage does not impact EpiPen Jr (0.15...